Company Sector
Cancer Peptide Vaccines
Cancer Peptide Vaccines includes companies developing peptide-based therapeutic vaccines for oncology. These programs are designed to train the immune system against tumor-associated or tumor-specific antigens and are often paired with broader immunotherapy strategies.
Why watch Cancer Peptide Vaccines
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Cancer Peptide Vaccines news
The latest feed items from companies currently grouped under Cancer Peptide Vaccines.
- 01
GLSIGreenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
Source: Greenwich LifeSciences
- 02
GLSIGreenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
Source: Greenwich LifeSciences
- 03
GLSIGreenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Source: Greenwich LifeSciences
- 04
GLSIGreenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
Source: Greenwich LifeSciences
- 05
- 06
GLSIGreenwich LifeSciences Provides Update on Upcoming AACR Meeting
Source: Greenwich LifeSciences
- 07
GLSIGreenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
Source: Greenwich LifeSciences
- 08
GLSIGreenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
Source: Greenwich LifeSciences
- 09
GLSIGreenwich LifeSciences Provides Update on Financing Strategy
Source: Greenwich LifeSciences
- 10
GLSIGreenwich LifeSciences Provides Update Regarding Form 10-K Filing
Source: Greenwich LifeSciences
- 11
GLSIGreenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
Source: Greenwich LifeSciences
- 12
GLSIGreenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Source: Greenwich LifeSciences
- 13
GLSIGreenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
Source: Greenwich LifeSciences
- 14
GLSIGreenwich LifeSciences Provides Update Regarding Form 10-K Filing
Source: Greenwich LifeSciences
Companies in Cancer Peptide Vaccines
2 companies tagged with Cancer Peptide Vaccines.
Frequently Asked Questions
What does the Cancer Peptide Vaccines sector include?
Cancer Peptide Vaccines includes companies developing peptide-based therapeutic vaccines for oncology. These programs are designed to train the immune system against tumor-associated or tumor-specific antigens and are often paired with broader immunotherapy strategies.
How many companies are currently tagged with Cancer Peptide Vaccines?
2 companies are currently grouped under Cancer Peptide Vaccines on BioPharmSignal.
Which companies are most visible in the Cancer Peptide Vaccines group right now?
GLSI, PDSB are among the companies currently shown on this sector page.
How can I watch news for Cancer Peptide Vaccines?
Use the Watch button on this page to subscribe to Cancer Peptide Vaccines headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Cancer Peptide Vaccines?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Cancer Peptide Vaccines.